Safeguarding Our Future January 11, 2016 • admin • Helping to prevent neurological damage from pesticide poisoning. Related News Pre-IND FDA Meeting held to obtain guidance on development of galantamine as a pre-treatment for nerve agent exposure. March 17, 2009 Countervail Corporation Awarded Additional $343,000 SBIR Phase II Grant for Continued Development of Medical Countermeasure to Nerve Agents September 9, 2013
